Press release
Immune Repertoire Sequencing Market worth US$560.5 million by 2030 with 9.6% CAGR | MarketsandMarkets Trademark
The global immune repertoire sequencing market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$354.6 million in 2025 and an impressive US$560.5 million by 2030
The global Immune Repertoire Sequencing Market [https://www.marketsandmarkets.com/Market-Reports/immune-repertoire-sequencing-market-151469626.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=immunerepertoiresequencingmarket], valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$354.6 million in 2025 and an impressive US$560.5 million by 2030. Rapid technological advancements and growing demand for personalized and precision medicines drive the market. In addition, growing applications in autoimmune disease research, the increasing use of IRS in organ transplant monitoring, and a rising focus on immunotherapy also propel market growth. Moreover, the combination of AI and ML and growing applications in vaccine development has opened significant prospects for market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151469626 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151469626&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=immunerepertoiresequencingmarket]
Browse in-depth TOC on "Immune Repertoire Sequencing Market"
450 - Tables
45 - Figures
400 - Pages
By Based on product, the IRS market is divided into assay kits & reagents and instruments & software. The large share of the assay kits & reagents segment can be attributed to the growing demand for reproducibility and standardization in immune profiling workflows. Moreover, as researchers and clinicians increasingly adopt IRS for applications in oncology, infectious diseases, vaccine development, and transplantation, the need for high-quality and ready-to-use kits has grown. These kits simplify complex procedures/workflow by bundling optimized reagents for sample preparation, library construction, and target enrichment, thus reducing variability and enabling more consistent results across studies and laboratories.
By Based on application, the IRS market is segmented into research, drug discovery & development, and clinical diagnostics. The research application segment accounted for the largest IRS applications market share in 2024. The large share of this segment is attributed to the increasing use of IRS to address unmet needs in cancer and autoimmune diseases. This dominance will continue throughout the forecast period as major players develop new technologies for better oncology and autoimmune disease treatment.
By geography, the IRS market is divided into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America held the largest share of the IRS market, followed by Europe. The Aisa Pacific registered the highest CAGR growth within the IRS market during the forecast period owing to its increasing application for research and clinical diagnostics, the adoption of IRS for transplantation-associated research, government initiatives, and industry collaborations.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=151469626 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=151469626&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=immunerepertoiresequencingmarket]
Key players in the IRS market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PacBio (US), Oxford Nanopore Technologies PLC (UK), 10X Genomics (US), Agilent Technologies (US), Danaher Corporation (US), Takara Bio Inc. (Japan), Azenta US Inc. (US), Adaptive Biotechnologies (US), BGI Group (China), Personalis, Inc. (US), and QIAGEN (Netherlands).
Illumina, Inc. (US):
leads the IRS market through platforms such as NovaSeq X and AmpliSeq TCR kits, supported by its BaseSpace bioinformatics tools. The company's high-throughput solutions enable comprehensive TCR/BCR profiling for IRS. Despite challenges such as high instrument costs and growing competition from long-read sequencing providers, Illumina maintains strong positioning due to global reach, R&D strength, and recent acquisitions, including Fluent BioSciences (July 2024), which enhance its single-cell and multi-omics capabilities.
THERMO FISHER SCIENTIFIC INC. (US):
offers Ion Torrent platforms and Oncomine assays for immune repertoire workflows, providing end-to-end sequencing solutions from sample prep to analysis. It faces competitive pressure from Illumina in TCR/BCR profiling. The July 2024 acquisition of Olink Holding AB strengthens its proteomics and NGS integration, enhancing immune monitoring capabilities. Strategic expansion and diagnostics-focused development remain key elements of its market presence.
PacBio (US):
supports the IRS market through HiFi sequencing systems such as Revio Trademark , enabling highly accurate full-length TCR/BCR analysis. Its long-read technologies support vaccine research and immune monitoring but face adoption hurdles due to cost and throughput limitations. A strategic alliance formed in September 2023 with Hamilton Registered , Integra Registered , Revvity Trademark , and Tecan Registered automates sample preparation and streamlines clinical and biopharma sequencing workflows.
Oxford Nanopore Technologies plc (UK):
provides portable, real-time IRS solutions through platforms such as MinION and PromethION, supporting native RNA/DNA sequencing. The company focuses on field-based and clinical applications, with innovations such as direct RNA kits enhancing immune response tracking. In February 2025, it announced certified compatibility with 10x Genomics' latest single-cell chemistries, strengthening its clinical utility and strategic position in high-accuracy, long-read sequencing.
10x Genomics, Inc. (US):
offers the Chromium Single Cell Immune Profiling platform, specializing in high-resolution TCR/BCR diversity analysis at the single-cell level. It serves as a niche provider within the IRS market, targeting applications requiring deep cellular insights. The February 2025 collaboration with Oxford Nanopore integrates GEM-X 3' and 5' chemistries with Nanopore's V14 platform, enhancing multi-platform compatibility for immune repertoire studies.
For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=151469626&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=immunerepertoiresequencingmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=immune-repertoire-sequencing-market-worth-us5605-million-by-2030-with-96-cagr-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/immune-repertoire-sequencing-market-151469626.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune Repertoire Sequencing Market worth US$560.5 million by 2030 with 9.6% CAGR | MarketsandMarkets Trademark here
News-ID: 4026990 • Views: …
More Releases from ABNewswire
Hypoparathyroidism Market to Experience Notable Growth in Forecast Span by 2034, …
The Key Hypoparathyroidism Companies in the market include - Ascendis Pharma, EnteraBio, Bridgebio/Calcil ytix Therapeutics, Shire, and others.
DelveInsight's "Hypoparathyroidism Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hypoparathyroidism, historical and forecasted epidemiology as well as the Hypoparathyroidism market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hypoparathyroidism market outlook, drug uptake, treatment scenario…
BLVD Wellness and Recovery Reaches 200 Five-Star Review in under One Year, Pavin …
BLVD Wellness and Recovery - Physiotherapy Burnaby, has surpassed 200 5-star Google reviews in under one year. The clinic is quickly being recognized as the Best Physiotherapy in Burnaby, gaining popularity from Shockwave Therapy, TMJ treatment, and Headache Relief with the Watson Headache Approach. Their multidisciplinary approach to recovery has been key to helping patients achieve faster, lasting results for thousands of Burnaby residents.
Image: https://www.abnewswire.com/upload/2025/10/d6e4ecfaa254aba170551c2ef88d74f3.jpg
Burnaby, BC - 1st Oct, 2025…
Lone Wolf Roofing Named Mandeville's Top Roofer for Reliable, Long-Lasting Roofi …
Lone Wolf Roofing is the best roofer in Mandeville, Louisiana.
Image: https://www.abnewswire.com/upload/2025/09/ce2b5d27163b427f4e9c65a26f1441c6.jpg
Lone Wolf Roofing, a premier Louisiana-based roofing company, today announced its expanded services in Mandeville, Louisiana, bringing homeowners and businesses unmatched craftsmanship, storm-ready durability, and the strongest warranties in the industry. Known for roofing done right the first time, Lone Wolf Roofing now offers Mandeville clients both a 100-Year Warranty and an industry-first promise: if roof installation does not begin…
Marginal Zone Lymphoma Market Growth Projections 2024-2034: DelveInsight Analysi …
The Key Marginal Zone Lymphoma Companies in the market include - Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others.
DelveInsight's "Marginal Zone Lymphoma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Marginal Zone Lymphoma, historical and forecasted epidemiology as well as the Marginal Zone Lymphoma market trends in the United States, EU4…
More Releases for IRS
Torchlight Tax Offers Free Ebook on Understanding IRS Notices
Torchlight Tax LLC, a full service tax firm, is offering a free ebook entitled Understanding IRS Notices.
Dave Horwedel, CEO of Torchlight Tax, says that many taxpayers are confused and traumatized by receiving an IRS notice.
Mr.Horwedel stated "The IRS sends out a wide variety of notices to taxpayers that often strike fear into the heart of that taxpayer. If you understand what each type of notice is and…
National Tax Debt Offers Help Amidst IRS Collections
Image: https://www.getnews.info/wp-content/uploads/2024/08/1724781499.png
The Internal Revenue Service (IRS) is gearing up to intensify tax collections after a temporary lull during the COVID-19 pandemic. This heightened focus is largely due to increased funding from the Inflation Reduction Act, which has enabled the IRS to expand its workforce and enhance its collection capabilities.
IRS Collections Resuming
Taxpayers who owe back taxes should be aware that the IRS is becoming more aggressive in its collection efforts. This…
Understanding IRS Notices and Navigating Effective Responses
Dealing with the Internal Revenue Service (IRS) can be a daunting task for many taxpayers. Whether it's a simple notification or a more complex issue, understanding the nuances of can significantly impact how one responds and resolves any issues presented.
Identifying Different Types of IRS Notices
The first step in managing Internal Revenue Service [https://sbkass.com/irs-notices-and-effective-responses/] communications effectively is to identify the type of notice you've received. The IRS sends various notices for…
IRS Decreases Tax Deductible Limits For Long-Term Care Insurance
The IRS has announced decreased tax-deductible limits for long-term care insurance for 2024 according to the American Association for Long-Term Care Insurance.
"This is a significant change in practice after yearly increases," states Jesse Slome, director of the American Association for Long-Term Care Insurance. "The 2024 deductible limits are still significant and few people, especially business owners, are aware that premiums paid for long-term care insurance may be tax deductible."
The just…
Things you need to know about IRS tax refunds
Tax season is here, and taxpayers across the United States are finalizing their tax filing strategies, as a high tax bill is not desirable at all. Taxpayers intend to obtain as much tax deduction as possible, and several attributes affect the total amount of taxes that are to be paid by a taxpayer. Every taxpayer needs to be aware of the IRS refunds they are entitled to so they can…
New Tool Quickly Calculates IRS Settlements
Old Hickory, Tenn. - TaxProEZ, a professional tax resolution and preparation company, announces the release of a new tool that helps enrolled agents quickly by calculating settlements. Tax resolution expert Gary LaRoy is offering the tool to enrolled agents, so they can support their clients’ tax management needs.
The Internal Revenue Service (IRS) is sure to come calling when back taxes are owed. The average accountant or tax professional company may…
